{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:24:16Z","timestamp":1775841856932,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI179706"],"award-info":[{"award-number":["R01AI179706"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XH1910661"],"award-info":[{"award-number":["W81XH1910661"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XH1910662"],"award-info":[{"award-number":["W81XH1910662"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126729","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:02:50Z","timestamp":1737021770000},"page":"126729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mucosal immunity elicited by a human-Fc\u03b3 receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens"],"prefix":"10.1016","volume":"48","author":[{"given":"Sudeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Hazlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangchun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.126729_bb0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126729_bb0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Collaborators","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10098","key":"10.1016\/j.vaccine.2025.126729_bb0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126729_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tim.2009.12.001","article-title":"Potential role for mucosally active vaccines against pneumococcal pneumonia","volume":"18","author":"Jambo","year":"2010","journal-title":"Trends Microbiol"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2025.126729_bb0025","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126729_bb0030","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126729_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126729_bb0040","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","article-title":"Vaccine adjuvants: current challenges and future approaches","volume":"98","author":"Wilson-Welder","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2025.126729_bb0045","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2741\/1452","article-title":"Current vaccine adjuvants: an overview of a diverse class","volume":"9","author":"Kensil","year":"2004","journal-title":"Front Biosci"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126729_bb0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.idc.2011.07.004","article-title":"Vaccines and vaccine adjuvants as biological response modifiers","volume":"25","author":"Speil","year":"2011","journal-title":"Infect Dis Clin N Am"},{"issue":"29","key":"10.1016\/j.vaccine.2025.126729_bb0055","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2217\/nnm-2021-0360","article-title":"Nanotechnology in adjuvants and vaccine development: what should we know?","volume":"16","author":"Assis","year":"2021","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.vaccine.2025.126729_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102307","article-title":"Towards the development of subunit vaccines against tuberculosis: the key role of adjuvant","volume":"139","author":"Duong","year":"2023","journal-title":"Tuberculosis (Edinb)"},{"issue":"24","key":"10.1016\/j.vaccine.2025.126729_bb0065","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126729_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOP.0000000000000868","article-title":"Toward precision adjuvants: optimizing science and safety","volume":"32","author":"Nanishi","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2025.126729_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","article-title":"Developments in Vaccine Adjuvants","volume":"2412","author":"Firdaus","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126729_bb0085","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1128\/IAI.05511-11","article-title":"Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcgamma receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity","volume":"80","author":"Bitsaktsis","year":"2012","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126729_bb0090","article-title":"Preclinical efficacy of a trivalent human FcgammaRI-targeted adjuvant-free subunit mucosal vaccine against pulmonary pneumococcal infection","volume":"8","author":"Kumar","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126729_bb0095","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.4049\/jimmunol.155.10.4996","article-title":"Construction and characterization of a humanized anti-gamma-Ig receptor type I (fc gamma RI) monoclonal antibody","volume":"155","author":"Graziano","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2025.126729_bb0105","first-page":"677","article-title":"Differential cultivation of Francisella tularensis induces changes in the immune response to and protective efficacy of whole cell-based inactivated vaccines","volume":"7","author":"Kumar","year":"2016","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126729_bb0110","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/JVI.00039-16","article-title":"Transient CD4+ T cell depletion results in delayed development of functional vaccine-elicited antibody responses","volume":"90","author":"Provine","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.126729_bb0115","article-title":"Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae","volume":"83","author":"Puchta","year":"2014","journal-title":"J Vis Exp"},{"issue":"7855","key":"10.1016\/j.vaccine.2025.126729_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.126729_bb0125","article-title":"An optimized Hemagglutination inhibition (HI) assay to quantify influenza-specific antibody titers","volume":"130","author":"Kaufmann","year":"2017","journal-title":"J Vis Exp"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126729_bb0130","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/CVI.00371-13","article-title":"Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein a","volume":"20","author":"Daniels","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126729_bb0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126729_bb0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41577-019-0261-1","article-title":"Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4049\/jimmunol.180.1.454","article-title":"B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms","volume":"180","author":"Rangel-Moreno","year":"2008","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126729_bb0150","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.1115369109","article-title":"Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection","volume":"109","author":"Onodera","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12887-016-0703-x","article-title":"Nasal carriage of common bacterial pathogens among healthy kindergarten children in Chaoshan region, southern China: a cross-sectional study","volume":"16","author":"Pan","year":"2016","journal-title":"BMC Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126729_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195098","article-title":"Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: a cross-sectional study","volume":"13","author":"Dunne","year":"2018","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.vaccine.2025.126729_bb0165","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1017\/S0950268816001461","article-title":"Nasopharyngeal bacterial carriage in young children in Greenland: a population at high risk of respiratory infections","volume":"144","author":"Navne","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2025.126729_bb0170","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/1471-2334-10-304","article-title":"Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease","volume":"10","author":"Mackenzie","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126729_bb0175","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Collaborators","year":"2018","journal-title":"The Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126729_bb0180","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae\u2019s virulence and host immunity: aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.126729_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/microorganisms9102136","article-title":"Francisella and Antibodies","volume":"9","author":"Kubelkova","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2025.126729_bb0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fcimb.2018.00115","article-title":"Adaptive immunity to Francisella tularensis and considerations for vaccine development","volume":"8","author":"Roberts","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.126729_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fmicb.2011.00026","article-title":"Immunity to Francisella","volume":"2","author":"Cowley","year":"2011","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA Glycoforms drive B cell affinity selection and determine influenza vaccine efficacy","volume":"162","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"38","key":"10.1016\/j.vaccine.2025.126729_bb0205","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1073\/pnas.1707950114","article-title":"Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization","volume":"114","author":"Maamary","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126729_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126729_bb0215","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/jcm.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza a wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126729_bb0225","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126729_bb0230","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/jvi.69.2.1339-1343.1995","article-title":"Intracellular neutralization of influenza virus by immunoglobulin a anti-hemagglutinin monoclonal antibodies","volume":"69","author":"Mazanec","year":"1995","journal-title":"J Virol"},{"issue":"607","key":"10.1016\/j.vaccine.2025.126729_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0240","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1038\/s41467-023-43842-7","article-title":"Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine","volume":"14","author":"Thwaites","year":"2023","journal-title":"Nat Commun"},{"issue":"39","key":"10.1016\/j.vaccine.2025.126729_bb0245","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.39.30029","article-title":"Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014\/15","volume":"20","author":"Pebody","year":"2015","journal-title":"Euro Surveill"},{"issue":"13","key":"10.1016\/j.vaccine.2025.126729_bb0250","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.284.13.1677","article-title":"Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts","volume":"284","author":"Hurwitz","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.126729_bb0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","article-title":"Tissue-resident T cells and other resident leukocytes","volume":"37","author":"Masopust","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126729_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.1500515","article-title":"Tissue-resident memory T cells and fixed immune surveillance in nonlymphoid organs","volume":"195","author":"Carbone","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126729_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104585","article-title":"Mucosal vaccines for SARS-CoV-2: triumph of hope over experience","volume":"92","author":"Pilapitiya","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126729_bb0270","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.126729_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2022.02.009","article-title":"Heterogeneity of tissue resident memory T cells","volume":"245","author":"Konjar","year":"2022","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126729_bb0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00915547","article-title":"The common mucosal immune system and current strategies for induction of immune responses in external secretions","volume":"7","author":"Mestecky","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2025.126729_bb0285","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126729_bb0290","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4049\/jimmunol.180.8.5548","article-title":"Utilization of fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis","volume":"180","author":"Rawool","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126729_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/840842","article-title":"Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcgammaRIIB","volume":"2015","author":"Franz","year":"2015","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126729_bb0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/hv.22908","article-title":"Correlates of protection to influenza virus, where do we go from here?","volume":"9","author":"Cox","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"43","key":"10.1016\/j.vaccine.2025.126729_bb0305","doi-asserted-by":"crossref","first-page":"15987","DOI":"10.1073\/pnas.0607564103","article-title":"Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination","volume":"103","author":"Kong","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126729_bb0310","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/erv.13.35","article-title":"Immunological assessment of influenza vaccines and immune correlates of protection","volume":"12","author":"Reber","year":"2013","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:03:21Z","timestamp":1743876201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":62,"alternative-id":["S0264410X2500026X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126729","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal immunity elicited by a human-Fc\u03b3 receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126729"}}